{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:32Z","timestamp":1786119392539,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/cji.0b013e3181b29133","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T10:24:55Z","timestamp":1261045495000},"page":"92-95","source":"Crossref","is-referenced-by-count":4,"title":["Intratumoral Therapy With Interferon-\u03b1 in a Locoregional Advanced Malignant Blue Nevus"],"prefix":"10.1097","volume":"33","author":[{"given":"Roger von","family":"Moos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-10-20210227","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/modpathol.3800516","article-title":"Unusual variants of malignant melanoma","volume":"19","author":"Magro","year":"2006","journal-title":"Mod Pathol"},{"key":"R2-10-20210227","first-page":"79","article-title":"Pathology and genetics of skin tumors","author":"Requena","year":"2006"},{"key":"R3-10-20210227","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-4362.1998.00370.x","article-title":"Malignant blue nevus of the scalp","volume":"37","author":"Calista","year":"1998","journal-title":"Int J Dermatol"},{"key":"R4-10-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0923-1811(92)90018-7","article-title":"Malignant blue nevus: a report of eight cases","volume":"4","author":"Mehregan","year":"1992","journal-title":"J Dermatol Sci"},{"key":"R5-10-20210227","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/1097-0142(19891115)64:10<2024::AID-CNCR2820641010>3.0.CO;2-V","article-title":"A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma","volume":"64","author":"Legha","year":"1989","journal-title":"Cancer"},{"key":"R6-10-20210227","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1158\/1078-0432.CCR-07-4123","article-title":"A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel","volume":"14","author":"Flaherty","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R7-10-20210227","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1097-0142(19880315)61:6<1071::AID-CNCR2820610603>3.0.CO;2-T","article-title":"Intralesional interferon-alpha therapy in advanced malignant melanoma","volume":"61","author":"von Wussow","year":"1988","journal-title":"Cancer"},{"key":"R8-10-20210227","first-page":"83","article-title":"Studies of interferons in the therapy of melanoma","volume":"18","author":"Kirkwood","year":"1991","journal-title":"Semin Oncol"},{"key":"R9-10-20210227","doi-asserted-by":"crossref","first-page":"180S","DOI":"10.1111\/1523-1747.ep12875497","article-title":"Role of interferons in the therapy of melanoma","volume":"95","author":"Kirkwood","year":"1990","journal-title":"J Invest Dermatol"},{"key":"R10-10-20210227","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1346-8138.1996.tb04040.x","article-title":"Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma","volume":"23","author":"Alpsoy","year":"1996","journal-title":"J Dermatol"},{"key":"R11-10-20210227","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1001\/archderm.1992.01680210064008","article-title":"Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy","volume":"128","author":"Edwards","year":"1992","journal-title":"Arch Dermatol"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e3181b29133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:36Z","timestamp":1786039896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-201001000-00010"}},"subtitle":["A Brief Communication"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181b29133","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}